Artificial Intelligence and its future potential in lung cancer screening

Authors

  • Christopher Joy Mathew Acute Medicine Department, Conquest Hospital, East Sussex Healthcare NHS Trust, United Kingdom. E-mail: christopherjoy9@yahoo.com
  • Ashwini Maria David Jubilee Mission Medical College and Research Institute, Kerala University of Health Sciences, Kerala, India
  • Chris Mariya Joy Mathew David Tvildiani Medical University, Tbilisi, Georgia

DOI:

https://doi.org/10.17179/excli2020-3095

Keywords:

artificial intelligence, lung neoplasms, early detection of cancer, machine learning, lung cancer screening, artificial intelligence and lung cancer, low-dose computed tomography, artificial intelligence in radiology, computer-aided diagnosis, convolutional neural networks (cnn)

Abstract

Artificial intelligence (AI) simulates intelligent behavior as well as critical thinking comparable to a human being and can be used to analyze and interpret complex medical data. The application of AI in imaging diagnostics reduces the burden of radiologists and increases the sensitivity of lung cancer screening so that the morbidity and mortality associated with lung cancer can be decreased. In this article, we have tried to evaluate the role of artificial intelligence in lung cancer screening, as well as the future potential and efficiency of AI in the classification of nodules. The relevant studies between 2010-2020 were selected from the PubMed database after excluding animal studies and were analyzed for the contribution of AI. Techniques such as deep learning and machine learning allow automatic characterization and classification of nodules with high precision and promise an advanced lung cancer screening method in the future. Even though several combination models with high performance have been proposed, an effectively validated model for routine use still needs to be improvised. Combining the performance of artificial intelligence with a radiologist’s expertise offers a successful outcome with higher accuracy. Thus, we can conclude that higher sensitivity, specificity, and accuracy of lung cancer screening and classification of nodules is possible through the integration of artificial intelligence and radiology. The validation of models and further research is to be carried out to determine the feasibility of this integration.

Downloads

Published

2020-12-11

How to Cite

Joy Mathew, C., David, A. M., & Joy Mathew, C. M. (2020). Artificial Intelligence and its future potential in lung cancer screening. EXCLI Journal, 19, 1552–1562. https://doi.org/10.17179/excli2020-3095

Issue

Vol. 19 (2020)

Section

Review articles

License

Copyright (c) 2020 Christopher Joy Mathew, Ashwini Maria David, Chris Mariya Joy Mathew

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).